BeOne Medicines revenue and financials

ONC · NASDAQ · USD

$361.65Change from previous close: +1.00%Absolute change: +$3.58

Close · October 5, 2026

In the fiscal year ended December 2025, BeOne Medicines reported revenue of $5.34B (+40.23% year over year). Net income was $286.93M, a net margin of 5.4%.

Annual revenue · 2025: $5.34B
  1. $1.07M2016
  2. $238.39M2017
  3. $198.22M2018
  4. $428.21M2019
  5. $308.87M2020
  6. $1.18B2021
  7. $1.42B2022
  8. $2.46B2023
  9. $3.81B2024
  10. $5.34B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+40.23%
2025 vs 2024
Net margin
5.4%
2024: -16.9%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue5,3433,8102,4591,4161,1763094281982381.1
Cost of revenue66959438028616570.771.228.75.00.0
Gross profit4,6743,2162,0791,1291,011—————
Selling, general and administrative2,0811,8311,5081,279990—————
Research and development2,1461,9531,7791,6411,4591,29592767926998.0
Operating income447-568-1,208-1,790-1,439-1,658-960-706-98.5-117
EBIT447-568-1,208-1,790-1,439—————
EBITDA579-401-1,124-1,727-1,393—————
Interest expense58.221.84.419.128.2—————
Pre-tax income417-533-826-1,961-1,439—————
Income tax13011255.942.819.210.47.0-15.82.20.1
Net income287-645-882-2,004-1,458-1,625-949-674-93.1-119
Net income to common shareholders287-645-882-2,004-1,458—————
Basic EPS0.20-0.47-0.65-1.49-1.21-1.50-1.22———
Diluted EPS0.19-0.47-0.65-1.49-1.21-1.50-1.22———
Average shares (basic)10910510410392.8—————
Average shares (diluted)1,4751,3691,3571,3411,2061,085781———